Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Nicola La Monica"'
Autor:
Gloria C. Koo, Daniela Peruzzi, Luigi Aurisicchio, Nicola La Monica, Gennaro Ciliberto, Wei Zen Wei
Publikováno v:
Human Gene Therapy. 25:121-131
Several cancer vaccine efforts have been directed to simultaneously cotarget multiple tumor antigens, with the intent to achieve broader immune responses and more effective control of cancer growth. Genetic cancer vaccines based on in vivo muscle ele
Autor:
Nicola La Monica, Lakshmi Bhagat, Dong Yu, Jimmy X. Tang, Sudhir Agrawal, Fu-Gang Zhu, Ekambar R. Kandimalla, Weiwen Jiang
Publikováno v:
Journal of Investigative Dermatology. 133:1777-1784
Psoriasis is a chronic inflammatory skin disease that involves the induction of T-helper 1 (Th1) and T-helper 17 (Th17) cell responses and the aberrant expression of proinflammatory cytokines, including IL-1β. Copious evidence suggests that abnormal
Autor:
Fu-Gang Zhu, Sudhir Agrawal, Ekambar R. Kandimalla, Jimmy X. Tang, Lakshmi Bhagat, Dong Yu, Daqing Wang, Nicola La Monica, Weiwen Jiang
Publikováno v:
Autoimmunity. 46:419-428
Systemic Lupus Erythematosus is an autoimmune disease characterized by production of autoantibodies against nucleic acid-associated antigens. Endogenous DNA and RNA associated with these antigens stimulate inflammatory responses through Toll-like rec
Autor:
Francois H.T. Duong, Nicola La Monica, Tanja Blumer, Ekambar R. Kandimalla, Markus H. Heim, Zuzanna Makowska
Publikováno v:
Journal of hepatology
Background & Aims The toll-like receptor 9 (TLR9) agonist IMO-2125 is currently evaluated in clinical trials for chronic hepatitis C therapy. The aim of this study was to investigate the in vivo mode of action of a closely related compound, referred
Autor:
Timothy J. Sullivan, Nicola La Monica, Ekambar R. Kandimalla, Sudhir Agrawal, Daqing Wang, Lakshmi Bhagat, Dong Yu
Publikováno v:
Nucleic Acids Research
Oligonucleotides containing an immune-stimulatory motif and an immune-regulatory motif act as antagonists of Toll-like receptor (TLR)7 and TLR9. In the present study, we designed and synthesized oligonucleotide-based antagonists of TLR7, 8 and 9 cont
Autor:
Daniela Peruzzi, Gennaro Ciliberto, Irene Pak, Ansuman Bagchi, Danilo R. Casimiro, Luigi Aurisicchio, Nicola La Monica, Arthur Fridman, Adam C. Finnefrock
Publikováno v:
Oncoimmunology
Functional T-cell epitope discovery is a key process for the development of novel immunotherapies, particularly for cancer immunology. In silico epitope prediction is a common strategy to try to achieve this objective. However, this approach suffers
Publikováno v:
Vaccine. 28:1201-1208
Pet dogs represent a valuable pre-clinical model to assess the efficacy of oncology drugs. Additionally, canine cancers occur with an incidence similar to that of humans and share many features with human malignancies including histological appearanc
Autor:
Angelos D. Gritzapis, Sonia A. Perez, Michael Papamichail, Arthur Fridman, Constantin N. Baxevanis, Nicola La Monica, Luigi Aurisicchio
Publikováno v:
Vaccine. 28:162-170
The HER-2/neu oncoprotein is a promising cancer vaccine target. We describe herein a novel HLA-A2.1-restricted epitope, encompassing amino acids 657-665 (AVVGILLVV), which is naturally presented by human breast and ovarian cell lines. HER-2/neu(657-6
Autor:
Saverio Giampaoli, Nicola La Monica, Daniela Peruzzi, Francesco Calvaruso, Gennaro Ciliberto, Giuseppe Mesiti, Elisa Scarselli, Ekambar R. Kandimalla, Sudhir Agrawal, Carmela Mennuni, Sridhar Dharmapuri, Gaetano Barbato, Luigi Aurisicchio
Publikováno v:
Molecular Therapy. 17:1804-1813
The human telomerase reverse transcriptase (hTERT) is an attractive target for human cancer vaccination because its expression is reactivated in most human tumors. We have evaluated the ability of DNA electroporation (DNA-EP) and adenovirus serotype
Autor:
Antonella Conforti, Gennaro Ciliberto, Luigi Aurisicchio, Antonella Biondo, Nicola La Monica, Daniela Peruzzi, Patrizia Giannetti
Publikováno v:
ResearcherID
Human leukocyte antigen (HLA)-A2.1 transgenic mice (HHD) represent a valuable model to study and predict the immunogenicity of vaccines against pathogens. However, HHD mice are unsuitable for in vivo studies of cancer vaccines against human tumor-ass